← Evidence map

ArticleThe Journal of urology2018

Re: Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results from a Phase 1/2 Open-Label Study.

Sam S ChangPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018

this papercites it

Re: Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results from a Phase 1/2 Open-Label Study. | OpenQuestion